Brookline Capital Management Forecasts BIOX Q3 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Equities research analysts at Brookline Capital Management dropped their Q3 2025 earnings per share estimates for Bioceres Crop Solutions in a research report issued on Thursday, February 13th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will earn ($0.05) per share for the quarter, down from their prior forecast of $0.02. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.12 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.02 EPS, FY2027 earnings at $0.66 EPS, FY2028 earnings at $0.77 EPS and FY2029 earnings at $0.97 EPS.

BIOX has been the topic of a number of other reports. Lake Street Capital lowered their price target on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a report on Friday, February 7th. Oppenheimer lowered their target price on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Tuesday, January 28th. Finally, Canaccord Genuity Group decreased their price objective on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Bioceres Crop Solutions has an average rating of “Buy” and a consensus price target of $9.88.

Bioceres Crop Solutions Trading Down 2.6 %

Shares of NASDAQ:BIOX opened at $4.83 on Monday. The company has a market cap of $302.89 million, a P/E ratio of 241.62 and a beta of 0.57. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. Bioceres Crop Solutions has a 1 year low of $4.42 and a 1 year high of $13.60. The stock’s fifty day moving average price is $6.39 and its 200-day moving average price is $7.49.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Bank of America Corp DE grew its position in shares of Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after purchasing an additional 3,735 shares in the last quarter. Jump Financial LLC purchased a new stake in shares of Bioceres Crop Solutions during the fourth quarter worth about $72,000. Northern Trust Corp purchased a new stake in shares of Bioceres Crop Solutions during the fourth quarter worth about $93,000. Maven Securities LTD purchased a new stake in shares of Bioceres Crop Solutions during the fourth quarter worth about $152,000. Finally, Ping Capital Management Inc. grew its position in shares of Bioceres Crop Solutions by 7.3% during the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after purchasing an additional 3,000 shares in the last quarter. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.